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Background: The rise of neurointerventional devices has created a demand for guide
systems capable of navigating to the carotid artery consistently regardless of tortuosity.
The shift toward large distal access catheters (DACs) and desire for greater trackability
have inspired the creation of flexible, supportive, large-lumen long guiding sheaths.
Recently, the Ballast long guiding sheath was introduced to provide stability and flexibility
while navigating neurointerventional devices through tortuous intracranial anatomy.
Objective: To report our experience using the Ballast long guiding sheath in a series of
patients undergoing a variety of neuroendovascular procedures.
Methods: We retrospectively identified all patients who underwent neuroendovascular
treatment with a long guiding sheath were selected from a prospectively maintained
endovascular database from January 2019 to November 2019. Baseline clinical
characteristics and procedural details were collected.
Results: A total of 68 patients were included, mean patient age 67.6 ± 13.6 years.
Of the patients treated, 52.9% (36/68) presented with stenosis, 25% (17/68) with
aneurysms, 13.2% (9/68) with stroke or emboli, 1.5% (1/68) with a tumor, 1.5% (1/68)
with an arteriovenous fistula (AVF), and 4.4% (3/68) with a carotid web. Of the patients
with stenosis, 20/36 (55.6%) were extracranial, and 16/36 (44.4%) were intracranial.
The Ballast long guiding sheath was used to deliver treatment devices for stenting
(37/68, 54.4%), flow diversion (12/68, 17.6%), mechanical thrombectomy (8/68, 11.8%),
endovascular coiling (5/68, 7.4%), liquid embolization (3/68, 4.4%), balloon angioplasty
(2/68, 2.9%), and balloon angioplasty with stenting (1/68, 1.5%). No Ballast-related
complications or adverse events were encountered.
Conclusions: We demonstrate the feasibility of the Ballast long guiding sheath
to successfully deliver modern neurointerventional treatment devices through
tortuous anatomy.
Keywords: endovascular therapy, aneurysm, stroke, stent, long guiding sheath
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INTRODUCTION

outcomes were gathered from the selected patients. Safety
outcome data included incidence of dissection, iatrogenic stroke,
or intraprocedural rupture.

As neuroendovascular intervention expands to new applications,
and especially as the devices used—from large-bore distal
access catheters (DACs) (1) to a wide range of flow diverters
(2, 3)—expand in both size and variety, it is increasingly
important for long guiding sheaths to be useable through
multiple access options, for a range of procedures, across lesion
locations. Delivery of large devices to the target location in the
cerebrovasculature necessitates large inner diameters (ID) to be
paired with trackability, especially under emergent conditions (4)
or through tortuous anatomies (5).
Furthermore, while transfemoral access has been the preferred
approach during neurointerventional procedures for decades (6),
recent studies have shown the promise of transradial access
for the diagnosis and treatment of various cerebral pathologies
with embolization, mechanical thrombectomy, microsurgical
aneurysm clipping, stenting, and balloon occlusion tests (7–9).
While studies of safety and efficacy of radial access are ongoing,
a key and understudied aspect of this procedure is the feasibility
of using current long guiding sheaths in this novel application
across disease states.
Long guiding sheaths are designed to provide stability while
advancing neurointerventional devices across the aortic arch
and distal flexibility for advancement in the carotid artery, but
analysis concerning the performance of guide technologies is
generally published only as subsidiary information to patient
outcomes from the treatment device (10). Furthermore, there
is scant published evidence concerning device performance
in both transradial and transfemoral applications across a
range of neuroendovascular procedures (11). In this report, we
describe our experience with the Ballast 088 long guiding sheath
(Balt USA, LLC) in diagnostic angiography as well as across
the treatment of various cerebrovascular diseases, including
aneurysms, acute ischemic stroke, intracranial and extracranial
stenosis, arteriovenous fistula (AVF), carotid webs, and tumors.

Endovascular Procedures
All embolization procedures were performed under general
anesthesia, while mechanical thrombectomy and carotid
stenting were performed under conscious sedation. Systemic
anticoagulation with heparin, radial cocktail, and/or Aggrastat,
were given during the procedure in the majority of cases.

Mechanical Thrombectomy
A Solumbra approach (12) was used in which a Ballast.088 long
guiding sheath, a DAC, and microcatheter were used to cross
the lesion. The Ballast was navigated into the vertical petrous
or proximal V3 vertebral segments. A stent retriever was then
deployed for 5–7 min and pulled back under aspiration along
with the DAC. Heparin was not administered in any of our
stroke cases; however, 2,000 units/bag are connected to flush
lines. GP2b/3a inhibitors were not routinely used. The procedure
was typically terminated after 60 min of intervention time. The
approach for radial cases utilizes a short 6 Fr Glidesheath Slender
(Terumo Interventional Systems). A radial cocktail (2.5 mg
verapamil, 2,000 U heparin, 200 mcg nitroglycerin) was then
infused to prevent radial spasms, and a roadmap image was
obtained to determine the size of the radial artery. Next, a 5 Fr
Simmons/Sidewinder Slender (Terumo Interventional Systems)
was advanced over a baby J wire. A stiff 035 exchange length wire
was then advanced to exchange the Sidewinder and remove the 6
Fr sheath. Finally, the Ballast long guiding sheath was navigated
over its dilator to the vessel of interest, and the procedure
was performed.

Carotid Stenting
The common carotid artery (CCA) was cannulated and mapped
under fluoroscopic guidance with a triaxial catheter system and
Ballast long guiding sheath. The guide wire and catheter were
then advanced into the distal CCA. A distal embolic protection
device was advanced into the distal cervical segment of the
internal carotid artery and the device deployed and the delivery
system withdrawn. A small balloon was typically advanced to
pre-dilate the lesion and a stent was deployed and then we postdilate and retrieve the distal embolic protection device. If results
were satisfactory, the catheters and sheaths were removed and a
closure device was used to close the arteriotomy site.

MATERIALS AND METHODS
Ethics
The studies involving human participants were reviewed and
approved by the MetroWest institutional review board. The
patients provided their written informed consent to participate
in this study.

Patient Selection

Liquid Embolization

All patients who underwent neuroendovascular treatment with
a Balt Ballast long guiding sheath were selected from a
prospectively maintained endovascular database at Valley Baptist
Medical Center from January 2019 to November 2019.

Liquid embolic agents were slowly introduced under fluoroscopic
control via a triaxial catheter system with the Ballast long guiding
sheath. Once in contact with the patient’s blood, the agent
precipitated into an embolus in situ and the catheters were
removed. The duration of the injection was ∼ 30 min.

Data Collection

Flow Diversion

Baseline clinical characteristics were recorded, including
demographic information, comorbidities, medication usage,
lesion characteristics, and target vessel location. Procedural
characteristics of interest included procedure type, fluoroscopy
time, operative room time, safety outcome rates, and patient

Frontiers in Neurology | www.frontiersin.org

Flow diverters were deployed through a microcatheter into the
parent artery by using a triaxial guide-catheter system with the
Ballast long guiding sheath. Fluoroscopy was used to ensure
correct apposition of the flow diverter, with additional CT
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TABLE 1 | Patient and lesion characteristics.
Characteristic

TABLE 1 | Continued
Frequency (N = 73)

Characteristic

Age, mean ± SD

67.6 ± 13.6

Radial/Brachiocephalic

Female (%)

34/68 (50%)

Cervical

Comorbidities
2/68 (2.9%)

Hypertension

55/68 (81%)

Chronic obstructive pulmonary disease

3/68 (4.4%)

Coronary artery disease

5/68 (7.4%)
3/68 (4.4%)

Atrial fibrillation

5/68 (7.4%)

Renal failure

7/68 (10.3%)

Hypothyroidism

1/68 (1.5%)

History of SAH

1/68 (1.5%)

History of ICH

0/68 (0%)

Hypersensitivity lung disease

Data are mean ± SD or n (%). SAH, subarachnoid hemorrhage; ICH, intracerebral
hemorrhage; AVF, arteriovenous fistula; TICI, thrombolysis in cerebral infarction; CCA,
common carotid artery; ICA, internal carotid artery; VA, vertebral artery; MCA, middle
cerebral artery; ECA, external carotid artery.

angiography used at the surgeon’s discretion. If there were no
evident complications, the delivery catheter was removed and the
procedure was completed.

Endovascular Coiling
A detachable platinum coil was inserted into the aneurysm with
fluoroscopic guidance using a triaxial catheter system with a
Ballast long guiding sheath for proximal support. Once within
the aneurysm, the coil was separated from the catheter and left to
occlude blood flow to the aneurysm. If necessary, multiple coils
were used.

2/68 (2.9%)
17/68 (25%)

History of stroke

23/68 (33.8%)

Hypercholesterolemia

7/68 (10.3%)

Lesion type
Stenosis
<50%

36/68 (52.9%)
0/35 (0%)

50–60%

1/35 (2.9%)

60–70%

8/35 (23%)

70–80%

9/35 (25.7%)

80–90%
<90%

Balloon Angioplasty
A balloon guide catheter was advanced through a Ballast
long guiding sheath into a blood vessel with fluoroscopic
guidance until correctly positioned. The balloon was then inflated
at the blockage site for 30–60 s intervals at 4–6 atm until
recanalization was obtained. Intra-arterial r-tPA was added once
distal embolization was observed. The procedure was terminated
and the introducer sheath was removed once flow through the
vessel was sufficiently restored.

7/35 (20%)
10/35 (28.6%)

Aneurysm

17/68 (25%)

Small (<5 mm)

7/16 (43.8%)

Medium (5–10 mm)

9/16 (56.2%)

Large (10–25 mm)

0/16 (0%)

Giant (≥25 mm)

0/16 (0%)

Ruptured

2/16 (12.5%)

AVF

1/68 (1.5%)

Stroke/Emboli

9/68 (13.2%)

TICI <2b

0/68 (0%)
4/68 (5.9%)

37/68 (54.4%)

Peripheral vascular disease

History of aneurysm

2/68 (2.9%)

ICA

Congestive heart failure

Diabetes mellitus

Frequency (N = 73)

Statistical Analysis
All statistics of a given metric were computed on the set of
patients for which the metric was reported. Categorical data are
presented as n/N (%), by category. Continuous data are presented
as mean ± standard deviation (SD) for symmetrical distributions,
else median ± interquartile range (IQR). Numerical data are
presented as mean ± standard deviation (SD), or n (%).
All computations were performed using the R programming
language (13).

0/7 (0%)

TICI 2c

3/7 (42.9%)

TICI 3

4/7 (57.1%)

Tumor

1/68 (1.5%)

Carotid web

3/68 (4.4%)

Lesion location
Anterior circulation

54/66 (81.8%)

Posterior circulation

12/66 (18.2%)

RESULTS
Patient Characteristics

Lesion location (artery)
CCA

1/67 (1.49%)

ICA

26/67 (38.8%)

VA
MCA

A total of 68 patients were included in the study, including
34 (50.0%) females and 34 (50.0%) males. Patient baseline
and lesion characteristics are presented in Table 1. Mean
patient age was 67.6±13.6 years. Of the patients treated, 52.9%
(36/68) presented with stenosis, 25% (17/68) presented with
aneurysms, 13.2% (9/68) presented with stroke or emboli,
1.5% (1/68) was treated for a tumor, 1.5% (1/68) for an
AVF, and 4.4% (3/68) were treated for a carotid web. Of the
patients treated with stenosis, 20/36 (55.6%) of the stenoses
were extracranial and 16/36 (44.4%) were intracranial. The

4/67 (6%)
15/67 (22.4%)

ECA

0/67 (0%)

Other

21/67 (31.3%)

Previously treated

7/66 (10.6%)

Anatomical tortuosity
(Continued)
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TABLE 2 | Procedure characteristics.
Characteristic

TABLE 2 | Continued
Frequency

Characteristic

Frequency

General anesthesia

29/67 (43.3%)

Radial

Thrombolytics

1/66 (1.52%)

Radiation exposure (min), median ± IQR

14.7 ± 13.3

Anticoagulant/Antiplatelet

58/68 (85.3%)

Fluoroscopy time (min), median ± IQR

14.7 ± 13.3

OR time (min), median ± IQR

110 ± 46.5

Balloon angioplasty

2/68 (2.94%)

Puncture to closure time (min), median ± IQR

Balloon angioplasty, stenting

1/68 (1.47%)

Endovascular coiling

5/68 (7.35%)

Flow diversion

12/68 (17.6%)

Procedure

Liquid embolization

3/68 (4.41%)

Mechanical thrombectomy

8/68 (11.8%)

Stenting

37/68 (54.4%)
11/68 (16.2%)

Surpass streamline

1/68 (1.47%)

Wingspan

5/68 (7.35%)

Y-stent

1/68 (1.47%)

Pipeline

6/68 (8.82%)

Onyx 18

3/68 (4.41%)

Penumbra

3/68 (4.41%)

XACT

9/68 (13.2%)

WEB

4/68 (5.88%)

41 ± 23

Data are median ± IQR or n (%). CCA, common carotid artery; ICA, internal carotid artery;
VA, vertebral artery; MCA, middle cerebral artery; ECA, external carotid artery.

extracranial stenoses were located in the right (10/19, 52.6%) and
left (9/19, 47.4%) internal carotid artery (ICA). The intracranial
stenoses were located in the right supraclinoid (1/16, 6.25%), left
supraclinoid (2/16, 12.5%), left middle cerebral artery (MCA)
M1 or M2 segment (4/16, 25%), right MCA M1 segment
(2/16, 12.5%), left vertebral artery (VA) (1/16, 6.25%), right
VA (2/16, 12.5%), basilar artery (BA) (1/16, 6.25%), right
pre-cavernous segment of the ICA (1/16, 6.25%), and right
posterior cerebral artery (PCA) P1-P2 segments (2/16, 12.5%).
All intracranial stenosis patients were symptomatic and failed
medical therapy at least once. These patients were treated with
a gateway balloon and typically underwent stenting with the
Wingspan Stent System (Stryker). Overall, 10.6% of the cases
were previously treated for their condition. Lesions were most
commonly located in the anterior circulation (54/66, 81.8%),
with the remaining lesions in the posterior circulation (12/66,
18.2%). Lesion locations included the ICA (26/67, 38.8%), the
MCA (15/67, 22.4%), the VA (4/67, 5.97%), and the CCA
(1/67, 1.49%).

Target treatment device
Viatrac

16/67 (23.9%)

ATLAS

1/68 (1.47%)

Resolute Onyx

11/68 (16.2%)

TIGER

1/68 (1.47%)

Gateway

3/68 (4.41%)

Solitaire

2/68 (2.94%)

Trevo

1/68 (1.47%)

Embotrap

1/68 (1.47%)

HydroFrame/HydroSoft

3/68 (4.41%)

Microcoils

1/68 (1.47%)

Procedure Characteristics

Optima

1/68 (1.47%)

Procedural characteristics are presented in Table 2. Thirtyseven of the 68 total patients underwent stenting treatment
(37/68, 54.4%), and the remaining patients were treated with
flow diversion (12/68, 17.6%), mechanical thrombectomy (8/68,
11.8%), endovascular coiling (5/68, 7.4%), liquid embolization
(3/68, 4.4%), balloon angioplasty (2/68, 2.9%), and balloon
angioplasty with stenting (1/68, 1.5%). The Ballast 088 long
guiding sheath length most frequently utilized was 90 cm
(58/68, 85.3%), followed by 80 cm (6/68, 8.82%), and 100 cm
(4/68, 5.9%). The Ballast tip was placed in the ICA (34/67,
50.7%), CCA (16/67, 23.9%), VA (6/67, 9.0%), ECA (2/67,
3.0%), and MCA (1/67, 1.5%) during these endovascular
procedures. The target location was reached with technical
success in all 68 patients. Median time for puncture to closure
was 41 ± 23 min, and median time for both fluoroscopy
and radiation exposure was 14.7 ± 13.3 min. Access points
included femoral (51/67, 76.1%) and transradial (16/67, 23.9%).
Severe radial loops were encountered in two patients (2/68,
2.9%), significant to severe ICA tortuosity was observed in
three patients (3/68, 4.4%), and moderate ICA tortuosity was
observed in 1 (1/68, 1.5%). Regardless of how acute the
angle encountered, we did not experience a single catheter
kink in any of our radial cases. Treatment-related procedural

Catheter position
CCA

16/67 (23.9%)

ICA

34/67 (50.7%)

VA

6/67 (8.96%)

MCA

1/67 (1.49%)

ECA

2/67 (2.99%)

Other

8/67 (11.9%)

Ballast length (cm)
80

6/68 (8.82%)

90

58/68 (85.3%)

100

4/68 (5.88%)

Placement of ballast tip
CCA

16/67 (23.9%)

ICA

34/67 (50.7%)

VA

6/67 (8.96%)

MCA

1/67 (1.49%)

ECA

2/67 (2.99%)

Other

8/67 (11.9%)

Access approach
Femoral

51/67 (76.1%)
(Continued)
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FIGURE 1 | Right middle cerebral artery stenosis. (A) Pre-procedure angiogram demonstrating intracranial stenosis of the right M1-MCA segment. (B) Ballast position
in the ICA petrous segment. (C) Post-balloon mounted stent deployment. (D) Final angiography showing no evidence of vasospasm or dissection.

Case 2: Right Carotid Stenting—Radial Approach

complications include mild spasm in the cervical segment
of one patient (1/68, 1.5%) with an aneurysm treated with
verapamil. Further, the approach was aborted in two patients
(2/68, 2.9%) due to complications unrelated to the Ballast long
guiding sheath. No Ballast-related complications or adverse
events were encountered.

A patient presented with recurrent transient ischemic attacks and
several comorbidities. Non-invasive imaging identified stenosis
of the right carotid bulb, and cerebral angiogram confirmed the
presence of a right carotid web (Figure 2). Carotid stenting via
a right radial approach was performed successfully. The Ballast
long guiding sheath was able to navigate the difficult acute angle
from the subclavian to the right common carotid without kinking
or ovalization, and without losing position during stent delivery.

Illustrative Cases
Case 1: Stenting of Right Middle Cerebral Artery
Stenosis

Case 3: Balloon-Assisted Coiling of a Posterior
Communicating Artery Aneurysm

A patient presented with a paraclinoid aneurysm treated
previously with a flow diverter, with 80–90% intracranial stenosis
of the right MCA M1 segment (Figure 1). During the stenting
procedure, severe proximal tortuosity was encountered. The
Ballast long guiding sheath was placed through the cervical loop
and into the horizontal petrous segment to enable better distal
support for the intermediate catheter, enabling successful stent
deployment. The patient had excellent angiographic results, with
complete resolution of the M1 stenosis, with no evidence of
dissection or vasospasm.

Frontiers in Neurology | www.frontiersin.org

A patient presented to the ER with complaints of headache,
altered mental status, right sided weakness, altered coordination,
and respiratory distress. The patient developed nausea and a
headache that intensified over time, and was unresponsive upon
arrival to the ER. CT showed SAH, a right midline shift, and a
large left temporal lobe hematoma measuring 4.8 × 5.5 cm, with
a volume of roughly 66 ml (Figure 3). The patient was transferred
to Valley Baptist for endovascular treatment with Hunt & Hess
3 and Fisher Grade 4 scores. Cerebral angiogram demonstrated
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FIGURE 2 | Right carotid stenting—radial approach. (A,B) Pre-procedure angiogram demonstrating a right carotid web. (C) Radial artery. (D) Ballast position
post-stenting (outlined).

the horizontal petrous segment. Successful deployment with
good conformity to the aneurysm walls resulted in excellent
angiographic outcomes.

a left fetal PCA aneurysm measuring 5.3 × 4.6 × 3.8 mm,
with a 3.2 mm neck. Balloon assisted coiling with a left side of
access was performed to preserve the ostium of the posterior
communicating artery (PCOM). A Ballast.088 long guiding
sheath was placed in the proximal cervical segment, and its large
ID enabled introduction of both the balloon and coiling catheter.
Post-interventional visualization demonstrated no significant
residual filling. The patient required a decompressive left frontal
craniectomy and placement of an EVD, which was removed after
13 days.

Case 5: Aspiration Thrombectomy for Right Middle
Cerebral Artery Occlusion
A patient presented with left side weakness, slurred speech,
and a NIHSS of 18. The patient was on rivaroxaban for
atrial fibrillation, and had a history of hypertension and
hyperlipidemia. Due to use of anticoagulants, IV-tTPA was
not administered, and the patient was transferred to Valley
Baptist Medical Center for further treatment. On arrival,
CT perfusion showed a right MCA penumbra, while CT
angiography demonstrated decreased flow to the right MCA
branches (Figure 5). The patient was treated with mechanical
thrombectomy for complete occlusion of the right M1. Access
was obtained with the Ballast 0.088 long guiding sheath,
which provided excellent arch support for delivery of a
large bore 0.072 aspiration catheter. Complete recanalization
and thrombolysis in cerebral infarction (TICI) 3 reperfusion
was achieved.

Case 4: Flow Diverter Deployment for Right Middle
Cerebral Artery Aneurysm
A patient was referred for evaluation of a MCA aneurysm
diagnosed on CT angiography after presenting with neck pain
from a fall. A diagnostic angiogram confirmed the presence
of a right MCA bifurcation aneurysm measuring 6.1 × 5.5
× 4.4 mm, with a 3.5 mm neck (Figure 4). Treatment with
a 6 × 3 mm single layer intrasaccular device was performed.
Mild tortuosity of the ICA required good proximal support
for the 0.021” delivery microcatheter. The Ballast 0.088 long
guiding sheath enabled distal navigation in this case to

Frontiers in Neurology | www.frontiersin.org
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FIGURE 3 | Balloon-assisted coiling of a posterior communicating artery aneurysm. (A) Pre-procedure angiogram demonstrating a large PCA aneurysm. (B) Proximal
anatomy. (C) Peri-coiling. (D) Post-coiling angiogram demonstrating no residual filling.

DISCUSSION

The development of flow diversion devices for the next
generation of neuroendovascular therapeutic techniques
prompted a paradigm shift from biaxial to triaxial delivery
systems; as flow diverters such as the PED have large selfexpanded diameters of up to 5.25 mm, the IDs of delivery
microcatheter increased accordingly (14–16). In parallel, the rise
of aspiration utilization in acute ischemic stroke (17, 18) has
led to the development of hyperflexible, large-bore DACs for
enhanced trackability (15, 19, 20). However, the hyperflexibility
of these catheters means that they depend on the guide catheter
or sheath for proximal shaft support (20). When used in
conjunction with long guiding sheaths, such as the Ballast,
these DACs can provide the proximal support needed while
simultaneously maintaining flexibility for improved navigation.
This system allows for the delivery of a wide range of therapeutic
devices through a larger ID, which is crucial for large modern
neuroendovascular devices, such as flow diverters (15, 21).
Several triaxial catheter systems with long guiding sheaths
have been used with success in endovascular procedures. One

In this report, we describe our experience with the Ballast.088
long guiding sheath to deliver treatment devices in a series of
patients with cerebrovascular disease, including intracranial and
extracranial stenosis, aneurysm, stroke, AVF, and carotid web.
Ballast can be used for direct access to the cerebral vasculature
or through a short vessel access sheath. In the present study,
the Ballast long guiding sheath was navigated to the desired
anatomical locations in the anterior or posterior circulation
successfully using both transradial and transfemoral access in
a range of patient anatomies. Compared to our experience
with predicate guide catheter systems, we found the Ballast
long guiding sheath to offer significantly improved support and
trackability in both the radial and femoral cases, navigating
higher without increasing the risk of dissection. Overall, Ballast
provided support for the delivery of treatment devices to a range
of target locations with technical success and with no Ballastrelated complications.

Frontiers in Neurology | www.frontiersin.org
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FIGURE 4 | Flow diverter deployment for right middle cerebral artery aneurysm. (A) Pre-procedure angiogram demonstrating right MCA aneurysm. (B) WEB flow
diverter deployment, demonstrating successful deployment with conformity to the aneurysm walls. (C) Post-procedure angiogram demonstrating successful
occlusion.

FIGURE 5 | Aspiration thrombectomy for right middle cerebral artery occlusion. (A) Pre-procedure angiogram demonstrating occlusion of the right M1 segment
(TICI 0). (B) Post-thrombectomy angiogram demonstrating TICI 3 reperfusion.

of the earliest models of long guiding sheaths developed is
the Flexor Shuttle Sheath (Cook Medical), which is reinforced
with coil, has a flat distal tip, and was initially designed for
carotid artery stenting (22). The Shuttle has been used for
endovascular treatment in multiple prospective and retrospective
studies since its early inception (7, 15, 23–25). In 2002, Ohki
et al. describe their initial experience using the Shuttle in
31 total patients for carotid artery stenting (26). Technical
success was achieved in 97% of patients, with a stroke unrelated
to the catheter itself occurring in 1 (1/31, 3.33%) patient.
The Shuttle has since been used flow diversion (25), manual
aspiration thrombectomy (24), and control angiography (27),
with similar rates of success. Despite propelling a new age
of long guiding sheaths, the Shuttle’s introducer sheath tip is

Frontiers in Neurology | www.frontiersin.org

stiff, and the sheath itself is less flexible than most guiding
catheters, challenging navigation of the Shuttle through tortuous
vessels and vertebral arteries (27). These limitations may lead
to complications such as vasospasm or dissection during
deployment of flow diverters or DACs. For these reasons, some
neurointerventionalists do not routinely use the Shuttle for
tortuous aortic anatomies (27).
Additional long guiding sheaths include the Neuron Max
(Penumbra) and AXS Infinity (Stryker). These advanced
catheter systems have also been widely used to deliver
treatment devices in diverse neuroendovascular procedures
in recent years. Many studies have been published using a
triaxial system with the Neuron Max long guiding sheath in
a number of endovascular procedures with good outcomes
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(24, 28–30). More recently, the AXS Infinity also achieved
high rates of technical success and few catheter-related
complications (3, 15, 22). Lin et al. describe their experience
with the AXS Infinity to deliver PED Flex treatment to 95
patients with cerebral aneurysms (22). They reported few
catheter access-related complications, including asymptomatic
iatrogenic dissection in one case (1/95, 1.1%) and groin
hematoma in one case (1/95, 1.1%) (22). Their findings
demonstrate the utility of long guiding sheaths in the
augmentation of neurointerventional procedures with a
triaxial system.
Both the Neuron Max and AXS Infinity offer improvements
to the catheter design compared to the earlier Flexor Shuttle
Sheath. Modifications including stainless steel braided shaft
reinforcement, larger outer and IDs, multiple transition zones,
and in the AXS Infinity, a round distal tip. Similar to Neuron
Max and AXS Infinity, Ballast is braid-reinforced with a
single lumen, variable stiffness, and a radiopaque zone at
the distal end; however, Ballast also has a luer hub on the
proximal end, a progressively softer coiled distal tip, and
extended hydrophilic coating to both improve navigation and
reduce friction. We believe that one of the most import
attributes of novel supportive guide catheters, like Ballast, is
to be soft enough to track around cervical loops and access
petrous segments without dissection. The Ballast sheath’s 0.100
inch distal outer diameter (OD) is smaller than predicate
long guiding sheaths, enhancing the atraumatic navigation of
Ballast through the tortuous neurovasculature. Furthermore, its
large proximal ID of 0.088 inch ensures compatibility with a
wide range of currently available endovascular devices. With
functional lengths ranging from 80 to 105 cm, this long guiding
sheath is optimally designed to accommodate distal anatomies.
Together, the key innovations of this system provide the
perfect balance between proximal support and distal softness
needed to achieve improved trackability, smooth navigation,
and kink resistance. A recent retrospective analysis comparing
NeuronMax and Ballast performance during thrombectomy
found shorter procedure times and faster puncture to access
time with Ballast (31). Rates of successful revascularization
and good 90-day outcomes were similar for both catheters
(31). In our experience, the design advancements with Ballast
enable the safe delivery of treatment devices in an atraumatic
manner without evidence of complications attributable to
its positioning.

experience with a relatively new long guiding sheath device
demonstrates the early clinical efficacy of the Ballast long guiding
sheath. Additional analyses should be conducted to compare
the outcomes of Ballast to the other existing models of long
guiding sheaths.

CONCLUSION
Long guiding sheaths provide crucial support for intracranial
catheters through distal circulation, enabling the successful
delivery of modern neuroendovascular treatment devices for a
range of disease states. Selecting the appropriate distal access
guiding systems for endovascular intervention requires sufficient
navigability without sacrificing supportability for working
devices. The design characteristics for the Ballast long guiding
sheath are tailored specifically to enhance treatment within
the distal vasculature, with variable stiffness, optimal lubricity,
and a small distal OD to improve pushability, trackability,
proximal support. We demonstrate the feasibility of using the
Ballast to successfully deliver modern neurointerventional
treatment devices to desired locations for a variety of
intracranial conditions.
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